Case File
efta-efta00641707DOJ Data Set 9OtherFrom: Eileen Alexanderson
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00641707
Pages
1
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Eileen Alexanderson
To: "Jeffrey Epstein ([email protected])" <[email protected]>
Subject: Yr end reports to investors
Date: Wed, 20 Feb 2013 22:32:24 +0000
Attachments: img-220172034-0001.pdf
2012 report will be available in a few weeks. For obvious reasons revenues in recent years have been
disappointing but skillful expense management has protected the bottom. Current yield has been modest and
impacted by decision to cut fewer trees in a weak environment. Normalized current yield was originally forecast
to be 2-4% but early years were expected to be lower.
Appraisal, last year, marked the portfolio of assets down 12% last year.
I do believe, though, this is all in the rear view mirror now.
Original Message
From: NY_730_9_XRX_COPYROOM_C1
Sent: Wednesday, February 20, 2013 5:21 PM
To: Eileen Alexanderson
Subject: Scan from a Xerox Color
Please open the attached document. It was scanned and sent to you using a Xerox Color.
Number of Images: 53
Attachment File Type: PDF
Device Name: NY 730 9 XRX COPYROOM C1
_
_ _
_
Device Location:
For more information on Xerox products and solutions, please visit http://www.xerox.com/
This email and any files transmitted with it are confidential
and intended solely for the person or entity to whom they are
addressed and may contain confidential and/or privileged
material. Any review, retransmission, dissemination or
other use of, or taking of any action in reliance upon this
information by persons or entities other than the intended
recipient is prohibited. If you have received this email in
error please contact the sender and delete the material from
any computer.
Apollo Global Management, LLC
EFTA00641707
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]URL
http://www.xerox.comRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.